Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
HKD 11.62
(1.93%)
HKD 11.62
(1.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Total Assets | 2.44 Billion | 2.79 Billion | 2.3 Billion | 2.32 Billion |
| Total Current Assets | 723.05 Million | 919.29 Million | 874.23 Million | 1.14 Billion |
| Cash And Short Term Investments | 408.08 Million | 611.26 Million | 566.44 Million | 950.04 Million |
| Cash and Cash Equivalents | 399.6 Million | 603.07 Million | 466.44 Million | 750.04 Million |
| Short Term Investments | 8.48 Million | 8.19 Million | 100 Million | 200 Million |
| Net Receivables | 142.38 Million | 136.42 Million | 224.52 Million | 135.76 Million |
| Inventory | 89.13 Million | 95.1 Million | 15.14 Million | 7.98 Million |
| Other Current Assets | 147.1 Million | 76.49 Million | 68.13 Million | 53.84 Million |
| Total Non-Current Assets | 1.72 Billion | 1.88 Billion | 1.42 Billion | 1.17 Billion |
| Net PPE | 1.45 Billion | 1.59 Billion | 1.39 Billion | 1.13 Billion |
| Good Will And Intangible Assets | 28.13 Million | 30.65 Million | 6.05 Million | 2.42 Million |
| Good Will | - | - | - | - |
| Intangible Assets | 28.13 Million | 30.65 Million | 6.05 Million | 2.42 Million |
| Long-Term Investments | 247.4 Million | 242.6 Million | -90.31 Million | -189.91 Million |
| Tax Assets | -6.16 Million | -242.6 Million | - | - |
| Other Non Current Assets | 6.16 Million | 250.8 Million | 121.86 Million | 230.77 Million |
| Other Assets | - | - | - | - |
| Total Liabilities | 1.65 Billion | 1.64 Billion | 1.05 Billion | 868.27 Million |
| Total Current Liabilities | 577.61 Million | 606.04 Million | 446.55 Million | 328.46 Million |
| Account Payables | 175.23 Million | 146.19 Million | 102.44 Million | 87.59 Million |
| Tax Payables | 4.51 Million | 4.19 Million | 5.01 Million | 1.41 Million |
| Short Term Debt | 203.19 Million | 171.6 Million | 26.89 Million | 14.1 Million |
| Deferred Revenue | -26.36 Million | - | - | - |
| Other Current Liabilities | 225.54 Million | 288.25 Million | 317.22 Million | 226.76 Million |
| Total Non Current Liabilities | 1.08 Billion | 1.04 Billion | 604.25 Million | 539.81 Million |
| Long-Term Debt | 340.91 Million | 243.67 Million | 511.45 Million | 449.69 Million |
| Deferred Revenue Non Current | 87.07 Million | 89.93 Million | 92.79 Million | 90.12 Million |
| Deferred Tax Liabilities Non Current | - | - | - | - |
| Other Non Current Liabilities | 651.47 Million | 709.35 Million | 541.35 Million | 473 Million |
| Other Liabilities | - | - | - | - |
| Total Equity | 790.43 Million | 1.15 Billion | 1.25 Billion | 1.45 Billion |
| Stock Holders Equity | 785.88 Million | 1.14 Billion | 1.24 Billion | 1.45 Billion |
| Common Stock | 399.39 Million | 399.39 Million | 374.93 Million | 360 Million |
| Retained Earnings | -1.78 Billion | -1.4 Billion | -802.32 Million | -256.74 Million |
| Accumulated other comprehensive income | 386.48 Million | 159.33 Million | 159.02 Million | 130.69 Million |
| Common Stock Equity | 785.88 Million | 1.14 Billion | 1.24 Billion | 1.45 Billion |
| Capital Lease Obligation | 193.36 Million | 236.44 Million | 89.79 Million | 80.91 Million |
| Total Investments | 241.23 Million | 250.8 Million | 9.68 Million | 10.08 Million |
| Total Debt | 544.1 Million | 415.28 Million | 538.35 Million | 463.79 Million |
| Net Debt | 144.5 Million | -187.79 Million | 71.9 Million | -286.24 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | 2.43 Billion | 2.43 Billion | 2.44 Billion | 2.44 Billion | 2.44 Billion | 2.71 Billion |
| Total Current Assets | 766.14 Million | 766.14 Million | 723.05 Million | 723.05 Million | 723.05 Million | 846.52 Million |
| Cash And Short Term Investments | 424.07 Million | 424.07 Million | 408.08 Million | 408.08 Million | 434.03 Million | 543.33 Million |
| Cash and Cash Equivalents | 411.23 Million | 411.23 Million | 399.6 Million | 399.6 Million | 417.65 Million | 534.75 Million |
| Short Term Investments | 4.22 Million | 4.22 Million | 8.48 Million | 8.48 Million | 7.89 Million | 8.58 Million |
| Net Receivables | 184.62 Million | 184.62 Million | 142.38 Million | 142.38 Million | 142.38 Million | 211.99 Million |
| Inventory | 6.89 Million | 6.89 Million | 89.13 Million | 89.13 Million | 9.89 Million | 14.35 Million |
| Other Current Assets | 150.54 Million | 150.54 Million | 147.1 Million | 147.1 Million | 145.21 Million | 76.83 Million |
| Total Non-Current Assets | 1.66 Billion | 1.66 Billion | 1.72 Billion | 1.72 Billion | 1.72 Billion | 1.87 Billion |
| Net PPE | 1.39 Billion | 1.39 Billion | 1.45 Billion | 1.45 Billion | 1.45 Billion | 1.59 Billion |
| Good Will And Intangible Assets | 24.44 Million | 24.44 Million | 28.13 Million | 28.13 Million | 28.13 Million | 31.96 Million |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | 24.44 Million | 24.44 Million | 28.13 Million | 28.13 Million | 28.13 Million | 31.96 Million |
| Long-Term Investments | 246.74 Million | 246.74 Million | 247.4 Million | 247.4 Million | 241.23 Million | 184.83 Million |
| Tax Assets | - | - | -6.16 Million | -6.16 Million | - | 8.58 Million |
| Other Non Current Assets | - | - | 6.16 Million | 6.16 Million | 6.16 Million | 54.34 Million |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 1.68 Billion | 1.68 Billion | 1.65 Billion | 1.65 Billion | 1.65 Billion | 1.75 Billion |
| Total Current Liabilities | 572.6 Million | 572.6 Million | 577.61 Million | 577.61 Million | 577.61 Million | 649.56 Million |
| Account Payables | 117.78 Million | 117.78 Million | 175.23 Million | 175.23 Million | 175.23 Million | 124.88 Million |
| Tax Payables | - | - | 4.51 Million | 4.51 Million | - | 3.77 Million |
| Short Term Debt | 223.61 Million | 223.61 Million | 203.19 Million | 203.19 Million | 176.83 Million | 229.79 Million |
| Deferred Revenue | 42.58 Million | 42.58 Million | -26.36 Million | -26.36 Million | - | - |
| Other Current Liabilities | 188.62 Million | 231.21 Million | 225.54 Million | 225.54 Million | 225.54 Million | 294.88 Million |
| Total Non Current Liabilities | 1.11 Billion | 1.11 Billion | 1.08 Billion | 1.08 Billion | 1.08 Billion | 1.1 Billion |
| Long-Term Debt | 171.86 Million | 171.86 Million | 340.91 Million | 340.91 Million | 340.9 Million | 239.28 Million |
| Deferred Revenue Non Current | - | - | 87.07 Million | 87.07 Million | - | 88.5 Million |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 943.5 Million | 943.5 Million | 651.47 Million | 651.47 Million | 740.44 Million | 775.53 Million |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | 744.24 Million | 744.24 Million | 790.43 Million | 790.43 Million | 790.43 Million | 964.9 Million |
| Stock Holders Equity | 739.69 Million | 739.69 Million | 785.88 Million | 785.88 Million | 785.88 Million | 960.35 Million |
| Common Stock | 399.39 Million | 399.39 Million | 399.39 Million | 399.39 Million | 399.39 Million | 399.39 Million |
| Retained Earnings | -1.83 Billion | -1.83 Billion | -1.78 Billion | -1.78 Billion | -1.78 Billion | -1.59 Billion |
| Accumulated other comprehensive income | 210.01 Million | 210.01 Million | 386.48 Million | 386.48 Million | 209.08 Million | 163.23 Million |
| Common Stock Equity | 739.69 Million | 739.69 Million | 785.88 Million | 785.88 Million | 785.88 Million | 960.35 Million |
| Capital Lease Obligation | 179.77 Million | 179.77 Million | 193.36 Million | 193.36 Million | 193.36 Million | 234.31 Million |
| Total Investments | 250.96 Million | 250.96 Million | 241.23 Million | 241.23 Million | 249.13 Million | 193.41 Million |
| Total Debt | 395.47 Million | 395.47 Million | 544.1 Million | 544.1 Million | 517.74 Million | 469.07 Million |
| Net Debt | -15.75 Million | -15.75 Million | 144.5 Million | 144.5 Million | 100.08 Million | -65.67 Million |
HPAIW
3923
JVTSF
XIACF
1143
0390